Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) Debt to Equity: 2010-2025

Historic Debt to Equity for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to $90.72.

  • Lifecore Biomedical's Debt to Equity rose 910.38% to $90.72 in Q2 2025 from the same period last year, while for May 2025 it was $90.72, marking a year-over-year increase of 910.38%. This contributed to the annual value of $90.72 for FY2025, which is 910.38% up from last year.
  • Per Lifecore Biomedical's latest filing, its Debt to Equity stood at $90.72 for FY2025, which was up 910.38% from $8.98 recorded in FY2024.
  • Lifecore Biomedical's 5-year Debt to Equity high stood at $90.72 for FY2025, and its period low was -$20.06 during FY2023.
  • For the 3-year period, Lifecore Biomedical's Debt to Equity averaged around $26.55, with its median value being $8.98 (2024).
  • As far as peak fluctuations go, Lifecore Biomedical's Debt to Equity tumbled by 1,894.05% in 2023, and later soared by 910.38% in 2025.
  • Over the past 5 years, Lifecore Biomedical's Debt to Equity (Yearly) stood at $0.96 in 2021, then increased by 16.43% to $1.12 in 2022, then tumbled by 1,894.05% to -$20.06 in 2023, then soared by 144.77% to $8.98 in 2024, then surged by 910.38% to $90.72 in 2025.